# New study offers hope for patients suffering from a rare form of blindness

**URL:** <https://archive.menshealtharchive.com/t/new-study-offers-hope-for-patients-suffering-from-a-rare-form-of-blindness/890>\
**Category:** Research Database\
**Created:** [November 4, 2018, 2:12am UTC](https://archive.menshealtharchive.com/t/new-study-offers-hope-for-patients-suffering-from-a-rare-form-of-blindness/890 "2018-11-04T02:12:01Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![menshealtharchive](https://yyz1.discourse-cdn.com/flex035/user_avatar/archive.menshealtharchive.com/menshealtharchive/32/587_2.png) [@menshealtharchive](https://archive.menshealtharchive.com/u/menshealtharchive)\
**Post date:** [November 4, 2018, 2:12am UTC](https://archive.menshealtharchive.com/t/new-study-offers-hope-for-patients-suffering-from-a-rare-form-of-blindness/890/1 "2018-11-04T02:12:01Z")

</div>

> **[New study offers hope for patients suffering from a rare form of blindness](https://www.sciencedaily.com/releases/2018/11/181101142900.htm)**
>
> A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates...

  
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with far fewer side effects than other medications.